Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Coronary Patients
100%
Adverse Outcomes
100%
Osteoprotegerin
100%
Coronary Heart Disease
44%
Peace
33%
Nonfatal Myocardial Infarction
22%
Plasma Parameters
22%
Stable Coronary Artery Disease
22%
Ischemic Heart
22%
Immunoassay
22%
RANK Ligand
22%
Circulating Levels
22%
Ischemic Stroke
22%
Heart Failure
22%
Coronary Revascularization
11%
United States
11%
Net Reclassification Index
11%
Receptor Activator of nuclear factor-B Ligand
11%
Prognostic Marker
11%
Glycoprotein
11%
Improved Outcomes
11%
Plasma Samples
11%
Cardiac Tissue
11%
Secondary Prevention
11%
Inflammatory Response
11%
Angiotensin-converting Enzyme Inhibitor (ACEi)
11%
Vascular Tissue
11%
Adverse Events
11%
Tumor Necrosis Factor Receptor 1 (TNFR1)
11%
Vascular Calcification
11%
Drug Therapy
11%
TNF-related Apoptosis Inducing Ligand (TRAIL)
11%
C-reactive Protein
11%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
11%
Complex Choice
11%
Inhibitor Therapy
11%
Non-modifiable Risk Factors
11%
C-statistic
11%
New Targets
11%
Cell Integrity
11%
Biomarker Research
11%
Targets for Therapy
11%
Healthcare Costs
11%
Predictive Utility
11%
Estimated Glomerular Filtration Rate
11%
Endothelial Cells
11%
Face Complex
11%
Decoy Receptor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
100%
Ischemic Heart Disease
100%
Osteoprotegerin
100%
Osteoclast Differentiation Factor
44%
Receptor
22%
Brain Ischemia
22%
Immunoassay
22%
Heart Muscle Ischemia
22%
Congestive Heart Failure
22%
Biological Marker
22%
Heart Infarction
22%
C Reactive Protein
11%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
11%
Blood Vessel Calcification
11%
Alternative Complement Pathway C3 C5 Convertase
11%
Inflammation
11%
Glycoprotein
11%
Nuclear Factor
11%
Tumor Necrosis Factor Receptor
11%
Pharmacotherapy
11%
Adverse Event
11%
Pathophysiology
11%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Morbidity
11%
Immunology and Microbiology
Osteoprotegerin
100%
Blood Plasma
100%
RANKL
44%
Blood Level
22%
Immunoassay
22%
RANK
22%
Morbidity
11%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
11%
Angiotensin
11%
Glycoprotein
11%
Glomerulus Filtration
11%
Drug Therapy
11%
Tumor Necrosis Factor Receptor
11%
Inflammation Response
11%
Vascular Tissue
11%
Revascularization
11%
Face
11%
C-Reactive Protein
11%
Endothelial Cells
11%
Complement Factor B
11%